Last Week in Cannabis #14
Last Week in Cannabis
August 31 – September 5, 2026 | Issue #14
Hey friend — welcome back to Last Week in Cannabis. A big development in the United States on the hemp front, Canada's cannabis and driving stats just got more encouraging, and the UK is finally moving toward a regulated CBD market. Let's get into it.
1. CANADA — Cannabis-Related Driver Deaths Have Been Declining Since Legalization
New data shows that cannabis's connection to driver fatalities in Canada has been steadily decreasing in the years following legalization in 2018. The trend runs counter to one of the most commonly cited fears ahead of legalization — that legal access would lead to more impaired driving incidents on Canadian roads.
Mary Jane's Take: This is one of the more quietly important data points to come out of Canada's legalization experience. The fear that legal cannabis would make roads more dangerous was sincere and understandable — but the numbers are moving in the opposite direction. That likely reflects a combination of factors: public awareness campaigns, law enforcement training, better access to information about impairment timelines, and the fact that legal consumers tend to be more informed than those buying from unregulated sources. The roads aren't perfectly safe — impaired driving of any kind remains a serious concern — but the trend here is genuinely good news.
2. CANADA — Ontario Is Reviewing Its Cannabis Oversight Structure This Summer
The provincial government has announced it will conduct a review of both the Ontario Cannabis Retail Corporation and the Alcohol and Gaming Commission of Ontario this summer. The review is focused on evaluating how effectively both agencies are performing their mandates in a cannabis market that has matured significantly since legalization.
Mary Jane's Take: Ontario is the largest cannabis market in the country, so how its oversight bodies function matters enormously for the whole industry. A government review of the agencies responsible for retail and compliance is a reasonable step eight years into legalization — the rules that made sense in 2018 may not be the right fit for a market that now generates nearly $200 million in monthly sales in the province alone. Worth watching to see what recommendations come out of it.
3. UNITED STATES — Trump Signed the Hemp THC Delay Into Law
We have been tracking this story for several weeks. President Trump signed a federal spending bill on September 2nd that delays most of the sweeping new federal restrictions on hemp-derived THC products from November 12th to December 11th. The House passed the bill 370 to 48 on September 1st — an overwhelming bipartisan margin — after the Senate approved it 90 to 6 in August.
The delay buys Congress another month to develop a regulatory framework for the $28 billion hemp industry rather than allowing a broad prohibition to take effect by default. One category is not delayed — products containing cannabinoids that cannot naturally occur in the cannabis plant lose federal hemp protection on the original November 12th date. The White House reportedly committed that no further extensions will be granted, intensifying the pressure on Congress to act before December 11th.
Mary Jane's Take: One month is not a lot of time. The bipartisan margins in both chambers show that very few lawmakers actually want to see a sudden prohibition of a massive consumer category — drinks, gummies, and vapes that millions of Americans use regularly. But wanting to avoid a ban and having a workable regulatory framework ready are two very different things. December 11th is now the hard deadline. This story is not resolved — it is just on a tighter clock.
4. UNITED KINGDOM — The UK Is Finally Moving Toward Its First Regulated CBD Products
The UK's Food Standards Agency is presenting a recommendation to ministers in England and Wales on September 16th to formally authorize the first three high-purity CBD novel food applications — linked to approximately 3,000 individual products currently on the market. The FSA first set out plans to regulate CBD as a novel food back in 2019, making this a seven-year process in the making. Authorization would bring those products into full regulatory compliance and give consumers confidence that what they are buying has been properly assessed for safety.
Mary Jane's Take: Seven years is a long time to wait for regulatory clarity on a product that millions of people in the UK are already using. But this is genuinely meaningful progress. The Novel Food framework requires rigorous safety assessment before a product can be formally authorized — and clearing that bar matters. For CBD users in the UK, formal authorization means the product you're buying has been properly reviewed, not just tolerated. It also signals that the era of the unregulated CBD grey market in Britain is starting to close.
That's your week — two from Canada, one from the United States, one from the UK. See you next Monday.
— Mary Jane
